Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

BIOPROJET SCR - Product Pipeline Review - 2012: New research report available at Fast Market Research


Print article Print article
2013-01-28 07:09:34 - Fast Market Research recommends "BIOPROJET SCR - Product Pipeline Review - 2012" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "BIOPROJET SCR - Product Pipeline Review - 2012" provides data on the BIOPROJET SCR's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, BIOPROJET SCR's corporate website, SEC filings, investor presentations and featured press releases, both from BIOPROJET SCR and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* BIOPROJET SCR - Brief BIOPROJET SCR overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of BIOPROJET SCR human therapeutic division.
* Overview of

pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of BIOPROJET SCR with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the BIOPROJET SCR's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/530150_bioprojet_scr_product_pipeline_review ..


Reasons to buy

* Evaluate BIOPROJET SCR's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of BIOPROJET SCR in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the BIOPROJET SCR's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with BIOPROJET SCR.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of BIOPROJET SCR and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
BIOPROJET SCR Snapshot
BIOPROJET SCR Overview
Key Information
Key Facts
BIOPROJET SCR - Research and Development Overview
Key Therapeutic Areas
BIOPROJET SCR - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
BIOPROJET SCR - Pipeline Products Glance
BIOPROJET SCR - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
BIOPROJET SCR Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
BIOPROJET SCR - Drug Profiles
BP-1.3656
Product Description
Mechanism of Action
R&D Progress
BP-1.4979
Product Description
Mechanism of Action
R&D Progress
tiprolisant
Product Description
Mechanism of Action
R&D Progress
BIOPROJET SCR - Pipeline Analysis
BIOPROJET SCR - Pipeline Products by Therapeutic Class
BIOPROJET SCR - Pipeline Products by Route of Administration
BIOPROJET SCR - Pipeline Products By Mechanism of Action
BIOPROJET SCR - Dormant Projects
BIOPROJET SCR - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
BIOPROJET SCR, Key Information
BIOPROJET SCR, Key Facts
BIOPROJET SCR - Pipeline by Indication, 2012
BIOPROJET SCR - Pipeline by Stage of Development, 2012
BIOPROJET SCR - Monotherapy Products in Pipeline, 2012
BIOPROJET SCR - Phase III, 2012
BIOPROJET SCR - Phase II, 2012
BIOPROJET SCR - Phase I, 2012
BIOPROJET SCR - Pipeline By Therapeutic Class, 2012
BIOPROJET SCR - Pipeline By Route of Administration, 2012
BIOPROJET SCR - Pipeline Products By Mechanism of Action, 2012
BIOPROJET SCR - Dormant Developmental Projects,2012

List of Figures
BIOPROJET SCR - Pipeline by Indication, 2012
BIOPROJET SCR - Pipeline by Stage of Development, 2012
BIOPROJET SCR - Monotherapy Products in Pipeline, 2012

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com